Thalassemia Treatment Market - PowerPoint PPT Presentation

About This Presentation
Title:

Thalassemia Treatment Market

Description:

Thalassemia Treatment Market is expected to cross USD 3763 Million by 2025 at a CAGR of 10.4%. – PowerPoint PPT presentation

Number of Views:80

less

Transcript and Presenter's Notes

Title: Thalassemia Treatment Market


1
Thalassemia Treatment Market 2020-2025
Industry Survey, Growth, Competitive
Landscapeand Forecasts to 2025
2
Thalassemia Treatment Market 2020-2025
Thalassemia Treatment Market Highlights
Click to add text
According to MRFR analysis, Thalassemia Treatment
Market is expected to register a CAGR of
10.4 during the forecast period of 2019 to
2025 and was valued at USD 1890.4 Million in
2018. Thalassemia is an inherited blood disorder
that is characterized by inadequate hemoglobin
and fewer red blood cells in the body than
normal. Hemoglobin is the substance in red blood
cells that allows them to carry oxygen. The
inadequate hemoglobin and fewer red blood cells
of thalassemia may cause anemia. The growth of
the Global Thalassemia Treatment Market is driven
by various factors such as rising incidence of
thalassemia, increasing pipeline drugs in
thalassemia, rise in awareness regarding
available treatment options for the treatment of
thalassemia, growing public awareness related to
preventive care and rise in demand for improved
curative gene therapy.

Click to add text
Click to add text
3
Thalassemia Treatment Market 2020-2025
Thalassemia Treatment Market Regional Analysis
  • The market has been divided, by region, into the
    Americas, Europe, Asia-Pacific, and the Middle
    East Africa. The Americas is expected to be the
    largest market owing to the increasing prevalence
    of thalassemia and rising per capita healthcare
    expenditure. The thalassemia treatment market in
    the Americas has further been branched into North
    America and Latin America, with the North
    American market divided into the US and Canada.
    The European thalassemia treatment market has
    been categorized as Western Europe and Eastern
    Europe. The Western European market has further
    been classified as Germany, France, the UK,
    Italy, Spain, and the rest of Western Europe. The
    thalassemia treatment market in Asia-Pacific has
    been segmented into Japan, China, India, South
    Korea, Australia, and the rest of Asia-Pacific.
  • Browse Complete Report with TOC _at_ https//www.mark
    etresearchfuture.com/reports/thalassemia-treatment
    -market-8595

Click to add text
4
Thalassemia Treatment Market 2020-2025
Thalassemia Treatment Market Segmental Analysis
  • The Global Thalassemia Treatment Market has been
    segmented based on type, treatment, and end-user.
  • The market, based on type, has been divided into
    alpha-thalassemia and beta-thalassemia. The
    alpha-thalassemia segment is likely to be the
    fastest during the forecast period as there is an
    increased incidence of alpha-globin disorders in
    the US and other Western nations.
  • The global thalassemia treatment market has been
    segmented based on treatment, into blood
    transfusions, iron chelation therapy, folic acid
    supplements, gene therapy, and bone marrow
    transplants. The blood transfusions segment is
    expected to be the fastest market as low risks
    are involved due to careful blood screening. For
    instance, about 56,000 population have major
    thalassemia, and there are at least 30,000 people
    that need regular blood transfusions to survive
    and 5,500 die perinatally due to
    alpha-thalassemia major.

5
Thalassemia Treatment Market 2020-2025
Thalassemia Treatment Market Key Players
  • Novartis AG (Switzerland),
  • Kiadis Pharma (Netherlands), 
  • Sangamo Therapeutics (US),
  • Gamida Cell (Israel), 
  • Acceleron Pharma, Inc. (US),
  • CELGENE CORPORATION (US), 
  • Bluebird Bio, Inc. (US)
  • Avail Free Sample _at_ https//www.marketresearchfutu
    re.com/sample_request/8595

Click to add text
6
ABOUT US
MARKET RESEARCH FUTURE At Market Research Future
(MRFR), we enable our customers to unravel the
complexity of various industries through our
Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports
(3R), Continuous-Feed Research (CFR), and Market
Research Consulting Services. MRFR team have
supreme objective to provide the optimum quality
market research and intelligence services to our
clients. Our market research studies by products,
services, technologies, applications, end users,
and market players for global, regional, and
country level market segments, enable our clients
to see more, know more, and do more, which help
to answer all their most important questions. In
order to stay updated with technology and work
process of the industry, MRFR often plans
conducts meet with the industry experts and
industrial visits for its research analyst
members. For more information kindly visit
www.marketresearchfuture.com or contact us at
info_at_marketresearchfuture.com Copyright 2018
Market Research Future All Rights Reserved. This
document contains highly confidential information
and is the sole property of Market Research
Future. No part of it may be circulated, copied,
quoted, or otherwise reproduced without the
written approval of Market Research Future.
7
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com